Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
This project aims to:
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of HCM in Egypt | per 100,000 population per year | through study completion, an average of 5 year |
| Determinants of clinical severity of HCM in Egypt | Several indicators describing the clinical symptoms and signs | through study completion, an average of 1 follow-up every year, and an average of 5 follow-ups throughout the study duration |
| Determinants of cardiac phenotype severity of HCM in Egypt | Several indicators describing the cardiac phenotype using multimodality imaging | through study completion, an average of 1 follow-up every year, and an average of 5 follow-ups throughout the study duration |
| Determinant of genotype severity of HCM in Egypt | To identify and report the genetic profile of HCM in Egypt. | through study completion, at least once at the time of inclusion |
| Study the basic mechanisms responsible for the HCM in Egypt | To study different phenotypes at a molecular and cellular level including genotype-phenotype correlation. | through study completion, at least once at the time of inclusion, or |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Egyptian patients diagnosed with hypertrophic cardiomyopathy (either obstructive or non-obstructive), and their family members (either apparently healthy or not) who are willing to participate in this registry.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Magdi H Yacoub, FRS OM | Contact | m.yacoub@imperial.ac.uk | ||
| Shehab M Anwer, MBBCh., MRes | Contact | +41788816333 | shehabanwer@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aswan Heart Centre - Magdi Yacoub Heart Foundation | Recruiting | Aswān | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002312 | Cardiomyopathy, Hypertrophic |
| D024741 | Cardiomyopathy, Hypertrophic, Familial |
| ID | Term |
|---|---|
| D009202 | Cardiomyopathies |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001020 | Aortic Stenosis, Subvalvular |
Not provided
Not provided
Not provided
Not provided
Not provided
Our biobank includes:
| D001024 |
| Aortic Valve Stenosis |
| D000082862 | Aortic Valve Disease |
| D006349 | Heart Valve Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |